Diloxanide - CAS 579-38-4
Catalog number: 579-38-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Diloxanide is a luminal amebicide used in the treatment of amebiasis which is an infection of the diegestive tract caused by amoebas of the entamoeba group. It is considered the choice for asymptomatic cyst carriers. It is a second line treatment after paromomycin when no symptoms are present in places where infections are not common.
Publictions citing BOC Sciences Products
  • >> More
Solid powder
Soluble in DMSO, not in water
-20°C Freezer
Diloxanide is used in the treatment of amebiasis.
Quality Standard:
In-house standard
Grams to Kilograms
Boiling Point:
356.2±42.0 °C | Condition: Press: 760 Torr
Melting Point:
175 °C
1.439±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
Canonical SMILES:
1.Branch portal vein pyaemia secondary to amoebic liver abscess.
Kenny C1, Sohan O1, Murray L1, Fox TP1. BMJ Case Rep. 2015 Jun 8;2015. pii: bcr2014209098. doi: 10.1136/bcr-2014-209098.
We describe a case of a young returning traveller who contracted amoebic dysentery while visiting India. She presented to a major London Hospital several months later with features suggestive of amoebic liver abscesses, a known sequelae of amoebiasis. MRI with intravenous contrast demonstrated an area of likely occlusion of the portal vein. The patient was treated with intravenous metronidazole for 10 days followed by diloxanide furoate, an intraluminal agent. The largest abscess was drained acutely under ultrasound guidance. The portal vein occlusion was treated medically without the use of anticoagulation. A repeat ultrasound at 6 weeks post-treatment confirmed patency of the portal vein indicating spontaneous recanalisation with antimicrobial therapy alone.
2.Cervical amoebiasis mimicking cervical carcinoma: A rare presentation of a common infection.
Ahuja A, Bhardwaj M. J Infect Public Health. 2015 Dec 31. pii: S1876-0341(15)00217-8. doi: 10.1016/j.jiph.2015.11.015. [Epub ahead of print]
Cervical amoebiasis is an extremely rare diagnosis with only a small number of published case reports. This disease may present as cervical growth mimicking cervical carcinoma. Owing to the similarity of the clinical presentation of bleeding per vagina and per speculum examination showing growth or ulcers, definitive diagnosis is made on microscopic examination only. We present a rare case of cervical amoebiasis in a 28-year-old, multiparous female who presented with a history of vaginal bleeding. The patient was treated with metronidazole and diloxanide furate, after which she recovered. Awareness of this rare entity is important for clinical suspicion and for the pathologist to identify trophozoites and make a diagnosis, preventing unwarranted investigations. Accurate diagnosis also facilitates quick management of a patient; as this disease is an infective pathology that can easily be treated by antibiotics.
3.Comparative artificial neural network and partial least squares models for analysis of Metronidazole, Diloxanide, Spiramycin and Cliquinol in pharmaceutical preparations.
Elkhoudary MM1, Abdel Salam RA2, Hadad GM3. Spectrochim Acta A Mol Biomol Spectrosc. 2014 Sep 15;130:222-9. doi: 10.1016/j.saa.2014.04.002. Epub 2014 Apr 13.
Metronidazole (MNZ) is a widely used antibacterial and amoebicide drug. Therefore, it is important to develop a rapid and specific analytical method for the determination of MNZ in mixture with Spiramycin (SPY), Diloxanide (DIX) and Cliquinol (CLQ) in pharmaceutical preparations. This work describes simple, sensitive and reliable six multivariate calibration methods, namely linear and nonlinear artificial neural networks preceded by genetic algorithm (GA-ANN) and principle component analysis (PCA-ANN) as well as partial least squares (PLS) either alone or preceded by genetic algorithm (GA-PLS) for UV spectrophotometric determination of MNZ, SPY, DIX and CLQ in pharmaceutical preparations with no interference of pharmaceutical additives. The results manifest the problem of nonlinearity and how models like ANN can handle it. Analytical performance of these methods was statistically validated with respect to linearity, accuracy, precision and specificity.
4.Development and application of a novel, dual-mode gradient, stability-indicating HPLC-DAD method for the simultaneous determination and purity assessment of mebeverine hydrochloride, diloxanide furoate and their corresponding major degradation products in combination with some gastrointestinal drugs in the form of oral doses.
Mabrouk M1, El-Fatatry H, Hewala I, Emam E. J Pharm Biomed Anal. 2013 Sep;83:249-59. doi: 10.1016/j.jpba.2013.04.013. Epub 2013 Apr 19.
A simple, precise, rapid, stability-indicating reversed phase high performance liquid chromatographic method with photodiode array detection was developed and validated for the determination of mebeverine hydrochloride in combination with sulpiride or with diloxanide furoate and metronidazole in the presence of their corresponding degradation products. Optimum separation was achieved in less than 10 min using an X-Bridge C18 column (150 mm × 4.6 mm i.d., 3.5 μm particle size); elution was accomplished via the application of a dual-mode solvent and flow rate gradient system. This elution system enables the separation of nine components within a cycle time of 15 min and with a resolution greater than 2.5. Detection was conducted at 230 nm, and purity assessment was performed using a photodiode array detector. The method has been validated with respect to specificity, linearity, accuracy, precision, limit of quantitation, limit of detection, robustness and ruggedness.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Chemical Structure

CAS 579-38-4 Diloxanide

Quick Inquiry

Verification code

Featured Items